Aviral Vij to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Aviral Vij has written about Randomized Controlled Trials as Topic.
Connection Strength
0.311
-
Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2023 01 15; 187:84-92.
Score: 0.185
-
Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review. J Nucl Cardiol. 2018 02; 25(1):137-149.
Score: 0.127